Gelonghui Feb. 21丨Jilin Aodong (000623.SZ) held a roadshow on February 21, 2024 to discuss “How is the filing and collection of Chinese medicine formula granules in the company?” The company replied that by the end of 2023, the company had completed the registration of 400 varieties of traditional Chinese medicine formula granules. Traditional Chinese medicine formula granules are the company's development business. The company has established complete, comprehensive and strict product standards, and achieved quality control throughout the process of formula granules from medicinal materials to finished products. It has shown significant advantages in the supply chain, quality assurance, and service system. The number and production capacity of traditional Chinese medicine formula granules can fully meet clinical needs and guarantee the company's competitiveness in terms of products. The company actively participated in the country's first centralized procurement of traditional Chinese medicine formula granules by an inter-provincial alliance, and selected from a variety of traditional Chinese medicine formula granules. As a modern traditional Chinese medicine product, traditional Chinese medicine formula granules not only maintain the properties and efficacy of traditional Chinese medicine tablets, but are also extremely convenient for patients to take. They have a high repurchase rate and broad market prospects.